コンテンツへスキップ
Merck

Posttranslational modification of microtubules by the MATCAP detyrosinase.

Science (New York, N.Y.) (2022-04-29)
Lisa Landskron, Jitske Bak, Athanassios Adamopoulos, Konstantina Kaplani, Maria Moraiti, Lisa G van den Hengel, Ji-Ying Song, Onno B Bleijerveld, Joppe Nieuwenhuis, Tatjana Heidebrecht, Linda Henneman, Marie-Jo Moutin, Marin Barisic, Stavros Taraviras, Anastassis Perrakis, Thijn R Brummelkamp
要旨

The detyrosination-tyrosination cycle involves the removal and religation of the C-terminal tyrosine of α-tubulin and is implicated in cognitive, cardiac, and mitotic defects. The vasohibin-small vasohibin-binding protein (SVBP) complex underlies much, but not all, detyrosination. We used haploid genetic screens to identify an unannotated protein, microtubule associated tyrosine carboxypeptidase (MATCAP), as a remaining detyrosinating enzyme. X-ray crystallography and cryo-electron microscopy structures established MATCAP's cleaving mechanism, substrate specificity, and microtubule recognition. Paradoxically, whereas abrogation of tyrosine religation is lethal in mice, codeletion of MATCAP and SVBP is not. Although viable, defective detyrosination caused microcephaly, associated with proliferative defects during neurogenesis, and abnormal behavior. Thus, MATCAP is a missing component of the detyrosination-tyrosination cycle, revealing the importance of this modification in brain formation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
抗ホスホヒストンH3 (Ser10)抗体、有糸分裂マーカー, Upstate®, from rabbit
Sigma-Aldrich
モノクロナール抗β-チューブリンIII マウス宿主抗体, clone SDL.3D10, ascites fluid
Sigma-Aldrich
抗チューブリン抗体、脱チロシン化済み, Chemicon®, from rabbit
Sigma-Aldrich
抗チューブリン抗体、δ 2, Chemicon®, from rabbit